Cereno Scientific releases Insights video season 2 episode 7 with Prof. Benza
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episode 7 of season 2 in the Insights Video Series has been released. The video highlights the rationale and design of the Phase 2 clinical trial in PAH with drug candidate CS1, a controlled-release formulation of valproic acid. It further provides commentary on the recently published research article in the medical journal Pulmonary Circulation about the design of the Phase II study with CS1. Participating in the video is Raymond L. Benza,